deaths (OS)

es-BC - TNBC - NA - all population breast cancer - triple negative es-BC - Triple negatif (TNBC) - (neo)adjuvant (NA) es-BC - TNBC - NA - all population

versus placebo
olaparib vs. placebo 1 certainty unassessablestatistically conclusive-29%